InnoCan Pharma (INNO.CN) said Wednesday after-trade that it intends to raise CA$1 million through a private placement of up to 535,000 units at CA$1.87 apiece.
Each unit is comprised of one share and one three-year warrant to buy a share at CA$2.50. Proceeds will be used for working capital.
The offering is expected to close on Sept. 17.
InnoCan shares closed down CA$0.25 at CA$2 on the Canadian Securities Exchange.